Introduction
Renal function can be assessed through multiple methods; one common approach is to estimate creatinine clearance. People with impaired renal function are 5.5 times more likely to die than those without. 1, 2 Adverse drug events and inappropriate prescribing related to renal function are estimated to occur in 20% to 46% of patients with impaired renal function, 91% of which may be preventable. [3] [4] [5] [6] [7] Computerized alerts can reduce prescribing errors associated with nephrotoxic medications, renally cleared medications, and renal impairment. 6, [8] [9] [10] [11] [12] However, the approach to presenting information to providers via alerts may affect how providers assess and use that information. [13] [14] [15] For example, if the alert information is unclear this can result in inappropriate prescribing and increased patient risks. 16 Alert effectiveness is related to its usability, defined as the 'extent to which a [alert] can be used by specified users to achieve specified goals with effectiveness, efficiency and satisfaction'. 17 Usability is influenced by the alert's interface display, which can be modified using human factors principles to improve safety. [18] [19] [20] Previously, we conducted an investigation to assess the use of alerts in outpatient care, which identified 44 factors that influence the human-computer interaction between providers and alerts, along with several weaknesses of alert designs. 20 For instance, providers suggested that the timing of creatinine clearance alerts be modified so they appear in response to specific medication orders, such as allopurinol and non-steroidal anti-inflammatory drugs. Thus, the present work was undertaken to redesign and evaluate creatinine clearance alerts. We hypothesized that redesigned alerts, which incorporated human factors principles, would significantly reduce prescribing errors compared to the original alerts. This investigation was part of a larger study, published elsewhere, 21 that examined efficiency, mental workload, perceived satisfaction, and prescribing errors across several alert types, but did not assess findings by alert type. Herein, we present findings specific to creatinine clearance alerts M A N U S C R I P T
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Reducing prescribing errors through creatinine clearance alert redesign 5 for the first time. Distinct contributions of this article also include prescribing errors for individual medications; an in-depth analysis of prescribing actions, including how prescribers responded to dose dependent versus contraindicated medications; and prescribers' utilization of laboratory results for resolving alerts.
Methods

Study design
Participants completed prescribing tasks for fictional patients. 22 Each participant completed two, 30-minute sessions (i.e., original and redesign) in a counterbalanced design, with a washout period of at least 2 weeks between sessions so participants would be less likely to remember the tasks in each session. They were informed that they could order, discontinue, or change any medications. All participants were able to choose a medical or pharmaceutical textbook worth up to $50 for each session as an acknowledgement of their time. 
Participants
Twenty VA providers (6 men, 14 women) participated, consisting of 14 physicians, 4 clinical pharmacists, and 2 nurse practitioners. Clinical pharmacists were included in this study because they have prescribing privileges in VA outpatient care and also receive alerts. None of the research team members were study participants. Additionally, none of the participants had any involvement in the development of study materials or data analysis. This sample size is within the acceptable range reported M A N U S C R I P T
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Providers were recruited through e-mail and face-to-face communication and were eligible to participate if they were staff at the VA primary care clinics, and had at least one year of experience with VA computerized provider order entry. Students and residents were excluded from the study.
Apparatus
Prototypes
Two prototypes were developed within a mock electronic health record. The original alerts ( Figure   1 .A) represented those in use at the VA. These alerts appear before the medication list is displayed, warning providers "pre-emptively". Alert redesigns (Figure 1 .B) were iteratively developed by a team that included human factors engineers and clinicians, and informed by our previous study, where we identified limitations of alert designs within outpatient care. 20 Redesigns were further informed by literature evidence and a VA advisory panel. 21, [29] [30] [31] Human factors principles incorporated in the redesigned alerts included presenting alerts in a tabular format 32 , embedding links to additional laboratory information 30 , adding information on medication risks 31 , and changing the timing of the alert so that it appeared in association with specific medications. For both alert designs, participants could access the 'Labs' tab in the mock electronic health record, but this required exiting the ordering process.
Scenarios
A pharmacist and physician developed two fictional patient scenarios to evaluate the alerts and reviewed the scenarios for completeness. Predefined, objective criteria for errors were developed apriori from Micromedex guidelines 33 (Table 1 , column 5) and used as the standard for error determinations.
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Reducing prescribing errors through creatinine clearance alert redesign 7 Scenarios included three medications that required adjustment or discontinuation due to renal impairment (Table 1) . For the original design, two creatinine clearance alerts were produced, each near the beginning of the associated scenario. These alerts presented a general warning about estimated creatinine clearance and other lab results when the prescriber first enters the computerized provider order entry system (see Figure 1A ). In contrast, redesigned alerts appeared immediately after order details for each medication were entered; thus, three alerts could appear. Additional prescribing tasks were interspersed between alerts to mimic workflow that occurs during patient care. Scenarios were identical between the two sessions, aside from the patient's name. Scenarios were pilot tested by three clinicians, not included as study participants, prior to data collection to ensure scenarios were clear, clinically appropriate, and followed standards of care.
Data Collection
Participants were recorded using Morae® (Okemos, MI) software which captures video of the computer screen actions. We collected qualitative data using the Think-aloud technique, where participants are asked to verbalize their thoughts as they use the alerts. [34] [35] [36] Debrief interviews were conducted if time permitted. All verbalized statements were recorded and transcribed for later analysis.
Data Analysis
Video data were evaluated to assess usability. These data were analyzed by one individual with previous usability evaluation experience who was not part of the alert redesign team. This individual reviewed the videos, examined computer screen actions, and transcribed Think-aloud statements to assess the usability of the alerts. A pharmacist who was involved in neither the scenario development nor the redesign effort reviewed the videos and used the predefined criteria to evaluate prescribing errors. Another pharmacist double-checked each categorization to ensure accuracy. 37 Prescribing errors and accessing laboratory results were compared across the two alert designs using Wilcoxon signed-rank 
Results
Prescribing errors related to renal impairment
Across the scenarios, participants made significantly fewer prescribing errors (n=26) when using the redesigned versus original creatinine clearance alerts (n=47, p=0.001; Figure 2A ). There were 43%
fewer prescribing errors with the redesigned alerts. Results for individual medications are shown in Figure 2B .
Prescribing Actions for dose-dependent verses contraindicated medications
As shown in Table 1 , allopurinol required at least a dose reduction, while spironolactone and ibuprofen were contraindicated for the scenarios. Table 2 outlines prescribing actions taken for each.
Providers appropriately decreased the dose of allopurinol three times more often when they encountered the redesigned alerts. Several prescribers incorrectly reduced the dose of spironolactone rather than canceling the order, although more prescribers cancelled spironolactone with the redesigned alert.
Usability of Creatinine Clearance Alerts
Usability findings are shown in Table 3 .
Accessing laboratory results
With the original alerts, additional laboratory information could only be accessed through the 'Labs'
tab, but when providers used the redesigned alerts, laboratory information was accessed 3.5 times more frequently using the 'more labs' hyperlink than the 'Labs' tab. Overall, there was a modest improvement in appropriately discontinuing the spironolactone with the redesigned alerts ( Figure 2B ), but this was not due to the ease of viewing laboratory results: 2 of 5 providers who viewed labs with the original alerts M A N U S C R I P T
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Discussion
To our knowledge, this scenario-based study is the first to systematically compare two different designs for creatinine clearance alerts. Other studies noted a 16% reduction in prescribing errors when renal dosing alerts occurred during medication dispensing, and as much as a 42% reduction in prescribing errors during medication ordering compared to no alert, but neither study compared different alert designs nor examined the application of human factors principles on prescribing safety. Four features of the redesigned alerts likely contributed to safer prescribing. First, the redesigned alerts occur closer to the time of medication decision-making, whereas the original alerts may have appeared too early in prescribing workflow, thereby increasing errors. The original alerts appeared before the provider attempted to order or select a medication. Recent literature advocates for preemptive alerts that appear before prescribing decisions which may minimize workflow interruptions. 39 However, when the original alerts were presented prior to medication selection, providers vocalized confusion about the alert's purpose and prescribing errors were significantly greater. This early timing for alerts requires the provider to remember that the patient has renal impairment and assumes providers will know which medications are contraindicated or require a dosage adjustment later in the workflow of the session when specific medications are ordered. Our findings provide evidence that safer prescribing M A N U S C R I P T
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Reducing prescribing errors through creatinine clearance alert redesign 10 occurs when alerts are provided closer to the point of decision-making -in this case, later in prescribing workflow -when the provider is attempting to prescribe a potentially harmful medication. The redesigned alerts are 'smarter' than the original alerts in that the redesigns are specific to renally dosed medications, whereas the original alerts appear regardless of what is being ordered. In cases where providers are not ordering any renal dosing medications, the redesign could also reduce inappropriate alerts as well as the number of alerts presented. Similarly, the later presentation of the alert indicated that providers may need some type of action, as indicated by the increased number of providers who adjusted doses when presented with the redesigned alerts.
Second, safer prescribing may have occurred in some cases because participants accessed laboratory results more frequently with the redesign, which included embedded links to lab results. This may facilitate clinical workflow by providing better data access, and allowing providers to more rapidly view information for clinical decision-making. Literature suggests that patient specific information, should be summarized and readily accessible within the alert, if solicited. 40 Third, the redesigned alerts displayed information in a tabular format, instead of one string of laboratory information. This format likely allowed providers to readily identify pertinent information when responding to alerts. Providers indicated the original design was difficult to read, and in one case, incorrectly interpreted the patient's renal function as acceptable; the original design assumes that the provider will recognize an abnormal creatinine clearance, whereas the redesigned alerts specify the creatinine clearance is 'low'.
Fourth, providing information regarding medication risk may promote safer prescribing. According to warning design literature, risk information is key to help individuals recognize the level of danger. 19, 29 With the redesigned alerts, safer prescribing occurred for two medications with risks of hepatotoxicity M A N U S C R I P T
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Despite improved safety for allopurinol and ibuprofen, errors still occurred. This may be because estimated creatinine clearance was slightly below the accepted threshold of 30 mL/min, and providers may be inclined to renew these medications as this simulated patient had no previous problems. Errors were unlikely due to providers completely overlooking the alerts, since participants were asked to think aloud as they encountered alerts.
21
Other factors may explain why errors remained high with spironolactone. Providers might have determined that hyperkalemia could be monitored and managed with other interventions like dietary restrictions rather than changing spironolactone. In the scenario, spironolactone needed to be cancelled because potassium was trending upward and above normal limits on the day of prescribing (Table 1) . 
Future Work
The overall error rate in our study, 60%, was still relatively high, but lower than reported in other studies of inappropriate renal prescribing, which found error rates of approximately 75%. 4 Future research should focus on elucidating providers' decision-making process. Additionally, differences between provider types should also be explored. With the redesign, some providers wanted information on dosing guidelines to inform their decisions. Providing dosing guidance may further reduce errors.
Results provide evidence that presenting alerts too early in the prescribing process may weaken safety, but the optimum timing for creatinine clearance alerts is unknown. Similarly, adding laboratory results
to the initial ordering screen should be evaluated. The redesigned alerts should also be piloted and evaluated in live clinical environments. Finally, because the Think-Aloud technique may confound time measurement 42 , time to address the alerts was not analyzed in this study, and future work should examine time required in both laboratory and clinical settings.
Limitations
Providers were aware that patients were simulated; potentially reducing the precision of their clinical decision-making compared to clinical practice. Only three medications were used to evaluate creatinine clearance alerts and a larger number of medications may produce different results. Furthermore, our predefined criteria for errors may be more conservative than actual practice. Providers' responses might differ for inpatient scenarios, although we do not have data to support this. Finally, providers were recruited from one VA medical center and other providers may have responded differently.
Conclusions
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Overall, alerts redesigned according to human factors principles led to safer prescribing for scenarios involving renal impairment. This study provides some of the first evidence on how to design creatinine clearance alerts to promote safety. Results indicate that creatinine clearance alerts should appear in association with specific medications, rather than as a general, 'preemptive' alert. Alerts should also present information regarding risks. Easy access to laboratory results may aid workflow and increase viewing of labs. Redesigned alerts significantly reduced errors for ibuprofen and allopurinol. Study findings may be used to improve medication safety for patients with renal impairment. 
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Reducing prescribing errors through creatinine clearance alert redesign 2 * Information in columns 2-4 was provided to the providers as part of the scenario introduction and tasks or was available within the mock EHR system for the fictitious patient. Information in column 5
(Correct/Incorrect Actions) was for researcher use only and was not provided to participants. Figure 1 shows the information presented for each alert design. † Abbreviations: Est CrCL: estimated creatinine clearance SCr: serum creatinine; BUN: blood urea nitrogen; K+: Potassium ‡Cancelling the medication was correct whether or not an alternative medication was ordered. Any alternative medication could be ordered and no assessment was made concerning the correct or incorrect prescribing of the alternative medication.
Reducing prescribing errors through creatinine clearance alert redesign 3 spironolactone and ibuprofen were considered incorrect. Cancelling any of these three medications was correct whether or not an alternative was ordered. See Table 1 for pre-defined correct and incorrect actions. ‡2 participants used both the Labs tab and the alert link for spironolactone, and 1 participant used both for allopurinol.
Reducing prescribing errors through creatinine clearance alert redesign 4 (Figure 1.B) , there is a risk the provider may inadvertently M A N U S C R I P T • This study provides some of the first evidence on how to design creatinine clearance alerts to promote safety for patients with renal impairment.
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• Links to more information within alerts allow providers to more easily view relevant lab results related to renal function.
• Alerts that describe potential adverse events associated with a medication may promote safer prescribing decisions for patients with renal impairment.
